Recruitment unclearEUCTR 2021-004790-31
A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Depression in bipolarity
This historical record does not confirm current site availability.
Historical research recordPoland + Spain
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with bipolarity. Other eligibility criteria apply.
- Listed locations
- Poland · Spain
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- 164
- Sponsor
- Janssen-Cilag International NV
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Poland, Spain
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2021-004790-31
- Official title
Show the full official title
A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression
Recruitment & locations
Status unknownPoland · Spain
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Janssen-Cilag International NV.
Who can participate?
This study is for people with bipolarity. Other eligibility criteria apply.
Want to explore more studies?
Explore studiesRelated studies
Optimal Treatment Duration with Olanzapine following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies
The Effect of a Six Week Intensified Pharmacological Treatment for Depression in bipolarity Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.